The effects of patient out-of-pocket costs on insulin use among people with type 1 and type 2 diabetes with Medicare Advantage insurance-2014-2018.

ABSTRACT:

Objective

To identify the association between insulin out-of-pocket costs (OOPC) and adherence to insulin in Medicare Advantage (MA) patients.

Data sources and study setting

The study is based on Optum Labs Data Warehouse, a longitudinal, real-world data asset with de-identified administrative claims and electronic health record data.

Study design

Using descriptive and multivariable logistic regression analyses, we identified the likelihood of patients with diabetes having ≥60 consecutive days between an expected insulin fill date and the actual fill date (refill lapse) by OOPC, categorized by $0, >$0-$20 (reference), >$20-$35, >$35-$50, and > $50 per 30-day supply.

Data collection/extraction methods

The study included MA enrollees with type 1 or type 2 diabete

SUBMITTER: McAdam-Marx C 

PROVIDER: S-EPMC10771896 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature